Mark Bower

12PUBLICATIONS
179CO-AUTHORS
PharmacogenomicsHaematological tumoursPredictive and prognostic markersMolecular medicineImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 20, 2025
Integrase inhibitors and paclitaxel for Kaposi sarcoma: Clinical relevance of pharmacological interaction.

Niroshan Dayalan, Suki Leung, Katherine Dahill

|Jan 11, 2024
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.

Chiara Pagani, Chiara Rusconi, Alessia Dalla Pria

|Oct 13, 2023
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

Pietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski

|May 16, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

|Jan 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Marco Tagliamento, Alessandra Gennari, Matteo Lambertini

|Nov 26, 2021
Castleman disease.

Antonino Carbone, Margaret Borok, Blossom Damania

Pageof 2

Frequent Collaborators

2 joint publications

Catherine Diefenbach

2 joint publications

Izidore S Lossos

2 joint publications

Alina S Gerrie

2 joint publications

Nadia Khan